Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Fish and Richardson
Merck
Colorcon
Queensland Health
McKesson
Fuji
Moodys

Generated: April 25, 2018

DrugPatentWatch Database Preview

DENDRID Drug Profile

« Back to Dashboard

When do Dendrid patents expire, and when can generic versions of Dendrid launch?

Dendrid is a drug marketed by Alcon and is included in one NDA.

The generic ingredient in DENDRID is idoxuridine. There are two drug master file entries for this compound. Additional details are available on the idoxuridine profile page.
Drug patent expirations by year for DENDRID
Medical Subject Heading (MeSH) Categories for DENDRID
Synonyms for DENDRID
(+)-5-Iodo-2 -deoxyuridine
(+)-5-Iodo-2-deoxyuridine
(+)-5-Iodo-2'-deoxyuridine
(+)-5-Iodo-2'-deoxyuridine, 98%
1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione
1-(2-Deoxy- -D-ribofuranosyl)- 5-iodouracil
1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-dione
1-beta-D-2'-Deoxyribofuranosyl-5-iodouracil
1336-77-2
134I656
16509-EP2281563A1
16509-EP2316459A1
1beta-D-2'-Deoxyribofuranosyl-5-iodouracil
2,4(1H,3H)-Pyrimidinedione,1-(2-deoxy-b-L-erythro-pentofuranosyl)-5-iodo-
2'-Deoxy-5-iodouridine
20495-EP2272827A1
20495-EP2298768A1
20495-EP2314585A1
33995-05-0
4-24-00-01235 (Beilstein Handbook Reference)
5-I-2'-dUrd
5-IODO-2-DEOXYURIDINE
5-Iodo-2'-deoxyuridine
5-Iodo-2'-deoxyuridine, >=99% (HPLC)
5-iodo-2'deoxyuridine
5-Iodo-deoxyuridine
5-Iododeoxyuridine
5-Iododesoxyuridine
5-Iodouracil deoxyriboside
5-IUDR
54-42-2
5IdU
5IUDR
888-04-0
AB0013659
AC-8219
AC1L1LE0
AC1Q77TF
AI3-50861
AJ-45810
AK-35587
AKOS015920431
Allergan 201
Allergan 211
Allergan-211
Antizona
ANW-32073
AOB5602
AS-13469
AX8021350
BDBM50370388
BPBio1_000061
BR-35587
BRN 0030397
BSPBio_000055
C-1149
C9H11IN2O5
CAS-54-42-2
CCG-220018
CCRIS 2827
CHEBI:147675
CHEMBL788
CJ-10798
CS-2346
CTK4D1152
D00342
D02IED
DB-009133
DB00249
Dendrid (TN)
DSSTox_CID_25238
DSSTox_GSID_45238
DSSTox_RID_80769
DTXSID2045238
EINECS 200-207-8
Emanil
ent-Idoxuridine
Epitope ID:138107
HE405380
Heratil
Herpe-Gel
Herpes-Gel
Herpesil
Herpid
Herpidu
Herplex
HERPLEX (TN)
Herplex liquifilm
HMS2090M10
HMS2095C17
HMS2230E10
HSDB 7479
HY-B0307
I0258
I381
ID2
Idexur
Idossuridina
Idossuridina [DCIT]
Idoxene
Idoxuridin
Idoxuridina
Idoxuridina [INN-Spanish]
idoxuridine
Idoxuridine (5-IdU)
Idoxuridine (JP17/USP/INN)
Idoxuridine [USAN:INN:BAN:JAN]
Idoxuridine [USAN:USP:INN:BAN:JAN]
Idoxuridine, European Pharmacopoeia (EP) Reference Standard
Idoxuridine, United States Pharmacopeia (USP) Reference Standard
Idoxuridinum
Idoxuridinum [INN-Latin]
IDU
Idu Oculos
Iducher
Idulea
Iduoculos
IDUR
IdUrd
Iduridin
Iduviran
Iododeoxyridine
Iododeoxyuridine
Iodoxuridine
IUDR
J-009907
J-700180
Joddeoxiuridin
Kerecid
Kerecide
KS-00000JH7
LGP81V5245
LS-160825
MCULE-5585466189
MFCD00134656
MLS002154175
MolPort-001-792-514
NCGC00016243-01
NCGC00179673-01
NCGC00179673-03
NSC 39661
NSC-39661
NU005386
NU006506
Oftan-IDU
Ophthalmadine
Prestwick3_000018
PubChem14202
s1883
SC-16201
SCHEMBL15850897
SCHEMBL3683
SK&F 14287
SK&F-14287
SKF 14287
SMP2_000072
SMR001233472
Spectanefran
SR-05000001510
SR-05000001510-4
Stoxil
Synmiol
TL8003566
Tox21_110324
Tox21_110324_1
UNII-LGP81V5245
Uracil, 5-iodo-1-(2-deoxy-beta-D-ribofuranosyl)-
uridine, 2'-deoxy-5-(iodo-131I)-
URIDINE, 2'-DEOXY-5-IODO-
Uridine, 5-iodo-2'-deoxy-
Virudox
XQFRJNBWHJMXHO-RRKCRQDMSA-N
ZINC3834173

US Patents and Regulatory Information for DENDRID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon DENDRID idoxuridine SOLUTION/DROPS;OPHTHALMIC 014169-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Deloitte
Chinese Patent Office
US Army
US Department of Justice
Citi
Teva
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.